CompanyKRSANasdaqWaltham, MA

Korsana Biosciences, Inc.

Korsana Biosciences develops shuttled antibodies for neurodegenerative diseases.

SEC EDGAR ClinicalTrials.gov korsana.com

424B3Sep 25Latest SEC filing

Sep 11Latest story

September 2026

Korsana Biosciences completes Cyclerion merger, closes $380 million private placement

Sep 11Quarterly updateKorsana Biosciences, Inc.